Can you take Direct oral anticoagulants (DOACs) with Omega-3 Fatty Acids (EPA/DHA)?
This is general information, not medical advice. Supplements can interact with medicines and health conditions. Always check with your doctor or pharmacist before starting or changing supplements.
What the evidence says
Rivaroxaban and the other direct oral anticoagulants (DOACs) block clotting factors directly, and omega-3 fish oil has a mild antiplatelet effect of its own, so combining them could in principle add to bleeding risk. The evidence says this concern is real but small: a 2024 meta-analysis of 11 randomised trials covering more than 120,000 people found no overall increase in bleeding with omega-3, but did find a dose-dependent increase with high-dose purified EPA; and in the REDUCE-IT trial of 4 g/day icosapent ethyl, serious bleeding occurred in 2.7% of patients versus 2.1% on placebo, a difference that did not reach statistical significance. Neither study looked at people on DOACs specifically, so the added risk on top of an anticoagulant has not been measured directly. Omega-3 is not a reason to stop either product, but if you take a DOAC, tell your prescriber about your fish oil, keep the dose consistent — the bleeding signal in trials appears at high EPA doses (around 4 g/day), well above a typical 1 g/day supplement — and report unusual bruising, nosebleeds, or blood in urine or stool promptly.
Read more
We check against a limited set of medications. Absence of a warning here is not evidence of safety. Always confirm with your pharmacist.